Shanghai MicroPort MedBot (Group) Statistics

Total Valuation

Shanghai MicroPort MedBot (Group) has a market cap or net worth of HKD 16.30 billion. The enterprise value is 16.63 billion.

Market Cap	16.30B
Enterprise Value	16.63B

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date	Mar 28, 2025
Ex-Dividend Date	n/a

Share Statistics

Shanghai MicroPort MedBot (Group) has 1.01 billion shares outstanding.

Current Share Class	n/a
Shares Outstanding	1.01B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	4.45%
Float	317.20M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	92.51
PB Ratio	52.57
P/TBV Ratio	57.02
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-20.62
EV / Sales	99.04
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-37.26

Financial Position

The company has a current ratio of 1.15, with a Debt / Equity ratio of 2.10.

Current Ratio	1.15
Quick Ratio	0.62
Debt / Equity	2.10
Debt / EBITDA	n/a
Debt / FCF	-1.30
Interest Coverage	-33.05

Financial Efficiency

Return on equity (ROE) is -126.88% and return on invested capital (ROIC) is -34.85%.

Return on Equity (ROE)	-126.88%
Return on Assets (ROA)	-28.33%
Return on Invested Capital (ROIC)	-34.85%
Return on Capital Employed (ROCE)	-99.62%
Revenue Per Employee	299,758
Profits Per Employee	-1.44M
Employee Count	646
Asset Turnover	0.11
Inventory Turnover	0.45

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +21.62% in the last 52 weeks. The beta is 1.19, so Shanghai MicroPort MedBot (Group)'s price volatility has been higher than the market average.

Beta (5Y)	1.19
52-Week Price Change	+21.62%
50-Day Moving Average	9.92
200-Day Moving Average	10.02
Relative Strength Index (RSI)	83.52
Average Volume (20 Days)	11,526,511

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Shanghai MicroPort MedBot (Group) had revenue of HKD 167.86 million and -806.22 million in losses. Loss per share was -0.84.

Revenue	167.86M
Gross Profit	42.59M
Operating Income	-698.16M
Pretax Income	-815.27M
Net Income	-806.22M
EBITDA	-625.80M
EBIT	-698.16M
Loss Per Share	-0.84

Full Income Statement

Balance Sheet

The company has 237.52 million in cash and 581.28 million in debt, giving a net cash position of -343.76 million or -0.34 per share.

Cash & Cash Equivalents	237.52M
Total Debt	581.28M
Net Cash	-343.76M
Net Cash Per Share	-0.34
Equity (Book Value)	276.93M
Book Value Per Share	0.31
Working Capital	77.98M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -404.65 million and capital expenditures -41.51 million, giving a free cash flow of -446.16 million.

Operating Cash Flow	-404.65M
Capital Expenditures	-41.51M
Free Cash Flow	-446.16M
FCF Per Share	-0.44

Full Cash Flow Statement

Margins

Gross Margin	25.37%
Operating Margin	-415.91%
Pretax Margin	-485.67%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Shanghai MicroPort MedBot (Group) does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-4.95%
FCF Yield	-2.74%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Shanghai MicroPort MedBot (Group) has an Altman Z-Score of 4.39.

Altman Z-Score	4.39
Piotroski F-Score	n/a